Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 41,504 | 27,178 | 19,453 | 7,014 | 1,496 |
Cost of Goods | 2,788 | 1,522 | 693 | 117 | 36 |
Gross Profit | 38,716 | 25,656 | 18,760 | 6,897 | 1,460 |
Operating Expenses | 52,245 | 52,213 | 44,353 | 42,124 | 51,037 |
Operating Income | -12,741 | -26,035 | -24,900 | -35,110 | -49,541 |
Interest Expense | 2,716 | 2,592 | 2,354 | 1,978 | 2,295 |
Other Income | 1,126 | 1,378 | -1,632 | 903 | -12,506 |
Pre-tax Income | -14,331 | -27,249 | -28,886 | -36,185 | -64,342 |
Income Tax | -509 | 93 | -100 | 89 | 90 |
Net Income Continuous | -13,822 | -27,342 | -28,786 | -36,274 | -64,432 |
Net Income | $-13,822 | $-27,342 | $-28,786 | $-36,274 | $-64,432 |
EPS Basic Total Ops | -0.14 | -0.30 | -0.28 | -0.41 | -0.83 |
EPS Basic Continuous Ops | -0.14 | -0.30 | -0.28 | -0.41 | -0.83 |
EPS Diluted Total Ops | -0.14 | -0.30 | -0.28 | -0.41 | -0.83 |
EPS Diluted Continuous Ops | -0.14 | -0.30 | -0.28 | -0.41 | -0.83 |
EPS Diluted Before Non-Recurring Items | -0.14 | -0.30 | -0.32 | -0.41 | -0.70 |
EBITDA(a) | $-12,304 | $-25,494 | $-24,918 | $-34,515 | $-48,940 |